Quad Technologies
Woburn
About Quad Technologies
Quad Technologies is disrupting cell separation and cell therapy workflows by providing researchers with a simple, cell-friendly capture and release technology for cell isolation. Their new MagCloudz™ Streptavidin Cell Separation kit, featuring novel QuickGel™ technology platform, enables straightforward, scalable and fast cell separation with unique magnetic particle dissociation, resulting in complete label free cells. For applications such as T Cell purification, stem cell isolation, circulating tumor cell (CTC) separation and immunotherapy, this unique solution offers drastically improved cell viability, purity and recovery while maintaining a native cellular phenotype.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $3.0M
- Funding stage: M&A
- Last round: Convertible Note (Oct 2016)
- Website: quadtechnologies.com
- Phone: 339.927.9663
Industries & Categories
Biopharma, Biotechnology, Clinical Trials, Information Technology
Social Profiles
Canonical: https://fsome.com/organization/quad-technologies-2417180 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.